Menu
GeneBe

rs137891647

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PM4PP5_Very_Strong

The NM_145199.3(LIPT1):c.875C>G(p.Ser292Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00069 in 1,613,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.00045 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00072 ( 0 hom. )

Consequence

LIPT1
NM_145199.3 stop_gained

Scores

2
2
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:8

Conservation

PhyloP100: 1.86
Variant links:
Genes affected
LIPT1 (HGNC:29569): (lipoyltransferase 1) The process of transferring lipoic acid to proteins is a two-step process. The first step is the activation of lipoic acid by lipoate-activating enzyme to form lipoyl-AMP. For the second step, the protein encoded by this gene transfers the lipoyl moiety to apoproteins. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 13. Read-through transcription also exists between this gene and the neighboring downstream mitochondrial ribosomal protein L30 (MRPL30) gene. [provided by RefSeq, Mar 2011]
MITD1 (HGNC:25207): (microtubule interacting and trafficking domain containing 1) Abscission, the separation of daughter cells at the end of cytokinesis, is effected by endosomal sorting complexes required for transport III (ESCRT-III). The protein encoded by this gene functions as a homodimer, with the N-termini binding to a subset of ESCRT-III subunits and the C-termini binding to membranes. The encoded protein regulates ESCRT-III activity and is required for proper cytokinesis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM4
Stoplost variant in NM_145199.3 Downstream stopcodon found after 401 codons.
PP5
Variant 2-99162832-C-G is Pathogenic according to our data. Variant chr2-99162832-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 285871.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LIPT1NM_145199.3 linkuse as main transcriptc.875C>G p.Ser292Ter stop_gained 2/2 ENST00000651691.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LIPT1ENST00000651691.1 linkuse as main transcriptc.875C>G p.Ser292Ter stop_gained 2/2 NM_145199.3 P1

Frequencies

GnomAD3 genomes
AF:
0.000447
AC:
68
AN:
152130
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000647
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000363
AC:
91
AN:
250868
Hom.:
0
AF XY:
0.000346
AC XY:
47
AN XY:
135656
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00268
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000511
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000715
AC:
1045
AN:
1461412
Hom.:
0
Cov.:
34
AF XY:
0.000714
AC XY:
519
AN XY:
726992
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00260
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000832
Gnomad4 OTH exome
AF:
0.000779
GnomAD4 genome
AF:
0.000447
AC:
68
AN:
152248
Hom.:
0
Cov.:
32
AF XY:
0.000376
AC XY:
28
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.000169
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.00375
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000647
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000783
Hom.:
0
Bravo
AF:
0.000442
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000305
AC:
37
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000763
EpiControl
AF:
0.000712

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Lipoyl transferase 1 deficiency Pathogenic:5
Pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteMay 21, 2020Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0106 - This gene is known to be associated with autosomal recessive disease. (N) 0205 - Variant is predicted to result in a truncated protein with less than 1/3 of the protein affected. (P) 0251 - Variant is heterozygous. (N) 0304 - Variant is present in gnomAD <0.01 for a recessive condition (101 heterozygotes, 0 homozygotes). (P) 0604 - Variant does not result in the loss of an established domain, motif, hotspot or informative constraint region. (N) 0704 – A comparable truncating variant has low previous evidence for pathogenicity, and has been observed in one family with fatal lactic acidosis (PMID: 27247813). (P) 0801 - Strong previous evidence of pathogenicity in multiple unrelated individuals with lactic acidosis and Leigh-like disease (ClinVar, PMID: 24341803, PMID: 31042466). (P) 0905 - No segregation evidence has been identified for this variant. (N) 1001 - Strong functional evidence supporting abnormal protein function. Patient fibroblasts were found to have minimal residual protein and reduced lipoyation and mitochondrial respiratory chain protein activity. (P) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -
Pathogenic, criteria provided, single submitterclinical testingBaylor GeneticsSep 01, 2017This mutation has been previously reported as disease-causing and was found twice in our laboratory in trans with a missense variant: in an 8-year-old female with low pyruvate dehydrogenase activity, intellectual disability, hearing loss, hypotonia, epilepsy, microcephaly, failure to thrive, hepatopathy, anisocytosis, 2 deceased siblings similarly affected; in a 9-year-old female with spastic quadriparesis, single seizure, failure to thrive, scoliosis. Heterozygotes would be expected to be asymptomatic carriers. -
Pathogenic, no assertion criteria providedliterature onlyOMIMDec 17, 2013- -
Likely pathogenic, criteria provided, single submitterclinical testingGreenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic CenterMay 10, 2023PVS1, PM3 -
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxJan 28, 2023Identified in one individual with Leigh syndrome and one individual with seizures, developmental delay and lactic acidemia; both individuals were compound heterozygous for another variant in LIPT1 (Soreze et al. 2013; Ni et al., 2019); Nonsense variant in the C-terminus predicted to result in protein truncation, as the last 82 amino acids are lost, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); This variant is associated with the following publications: (PMID: 28803783, 25326635, 24341803, 29681092, 31042466) -
Pathogenic, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 10, 2016- -
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 24, 2023This sequence change creates a premature translational stop signal (p.Ser292*) in the LIPT1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 82 amino acid(s) of the LIPT1 protein. This variant is present in population databases (rs137891647, gnomAD 0.2%). This premature translational stop signal has been observed in individual(s) with clinical features of lipoyltransferase 1 deficiency (PMID: 24341803, 31042466; externalcommunication). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 285871). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects LIPT1 function (PMID: 31042466). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.33
D
BayesDel_noAF
Pathogenic
0.32
Cadd
Pathogenic
35
Dann
Uncertain
0.98
Eigen
Uncertain
0.38
Eigen_PC
Benign
0.11
FATHMM_MKL
Benign
0.54
D
MutationTaster
Benign
0.98
D;D;D;D;D;D
Vest4
0.21
GERP RS
4.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs137891647; hg19: chr2-99779295; COSMIC: COSV60739972; COSMIC: COSV60739972; API